Sympathetic Mapping/ Ablation of Renal Nerves Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 25, 2022

Study Completion Date

December 31, 2026

Conditions
Hypertension
Interventions
DEVICE

SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator

Radiofrequency ablation of renal arterial sympathetic nerves

Trial Locations (15)

100038

Peking University First Hospital, Beijing

100044

Peking University People's Hospital, Beijing

163458

Daqing Oilfield General Hospital, Daqing

200032

Shanghai Zhongshan Hospital, Fudan University, Shanghai

210000

Nanjing First Hospital, Nanjing

210029

Jiangsu Province Hospital, Nanjing

221004

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

300192

Tianjin First Center Hospital, Tianjin

400016

The Second Afflicted Hospital of Chongqing Medical University, Chongqing

430060

Renmin Hospital of Wuhan University, Wuhan

518020

Shenzhen People's Hospital, Shenzhen

610041

West China Hospital, Sichuan University, Chengdu

050000

Norman Bethune International Peace Hospital, Shijiazhuang

050057

Hebei General Hospital, Shijiazhuang

030009

Taiyuan Central Hospital, Taiyuan

All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

SyMap Medical (Suzhou), Ltd.

INDUSTRY